Results 211 to 220 of about 316,749 (274)

Stent Fracture and Perforation During Percutaneous Coronary Intervention for In-Stent Restenosis. [PDF]

JACC Case Rep
Khan SU, Arshad HB, Kleiman NS, Shah AR.
europepmc   +1 more source

B lymphocytes and hyperglycemia synergistically exacerbate coronary in-stent restenosis. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Yang D, Ni S, Liu S, Wang C, Yang K, Bi L, Yue Z, Hang L, Zhang M, Gao H.   +9 more
europepmc   +1 more source

Effect of the prognostic nutritional index on stent restenosis in patients with chronic coronary syndrome. [PDF]

Turk J Med Sci
Kardeşler B, Baştuğ S, Kalkan K, Erdoğan M, Külekci F, Çalapkulu MY, Beton N, Aslan AN, Corut Güzel H, Durmaz T.   +9 more
europepmc   +1 more source

Integrated CT-derived fractional flow reserve and perivascular fat attenuation index: a multimodal approach to predict in-stent restenosis. [PDF]

Front Cardiovasc Med
Zhao W, Huang L, Zhu M, Li X, Liu X, Zhang W, Shao C, Li Y.   +7 more
europepmc   +1 more source

Threshold effect of systemic immune-response index on in-stent neoatherosclerosis among patients with drug-eluting stent restenosis. [PDF]

Eur J Med Res
Yang S, Xia Q, Gu N, Shen C, Deng C, Wang X, Deng Y, Hu X, Zhu J, Zhao R, Shi B.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

In-stent Restenosis

Interventional Cardiology Clinics, 2016
In-stent restenosis (ISR) is the narrowing of a stented coronary artery lesion. The mean time from percutaneous coronary intervention (PCI) to ISR was 12 months with drug-eluting stents (DES) and 6 months with bare metal stents (BMS). ISR typically presents as recurrent angina. The use of DES has significantly reduced the rate of ISR compared with BMS.
Michael S, Lee, Gaurav, Banka
semanticscholar   +5 more sources

In-Stent Restenosis

2018
Restenosis is an arterial wall healing response to mechanical injury at the site of a previously treated coronary segment. In-stent restenosis (ISR) is an angiographic diagnosis, defined as recurrent diameter stenosis >50% within a stent or at its edges (5 mm segments proximal and distal to the stent).
Roisin Colleran, Robert A. Byrne
openaire   +2 more sources

In-Stent Restenosis

Interventional Cardiology Clinics, 2022
In-stent restenosis (ISR) remains a potential complication after percutaneous coronary intervention, even in the era of drug-eluting stents, and its treatment remains suboptimal. Neoatherosclerosis is an important component of the pathology of ISR and is accelerated in drug-eluting stents compared with bare-metal stents.
Kenji, Kawai, Renu, Virmani, Aloke V, Finn   +2 more
openaire   +2 more sources

Waksman In-Stent Restenosis Classification: A mechanism-based approach to the treatment of restenosis.

Cardiovascular Revascularization Medicine, 2021
Despite contemporary advances in stent technology, in-stent restenosis (ISR) remains a common issue following percutaneous coronary intervention. A novel classification system based on underlying mechanism of action of restenosis was recently introduced.
Evan Shlofmitz, Brian C. Case, Yuefeng Chen, C. Chezar-Azerrad, H. Hashim, H. García-García, G. Mintz, R. Waksman   +7 more
semanticscholar   +1 more source